Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities, as per the MHRA-approved Summary of Product Characteristics (SmPC) for Mounjaro
Egyes gabonaflk, mint pldul a rizskorpa, szintn jelents forrsai ennek a fontos tripeptidinek
Simultaneously, their action on hypothalamic and brainstem appetite centres reduces food-seeking behaviour and overall caloric intake
Combination analgesic drugs containing butalbital, such as Fioricet, Fiorinal, or Esgic CGRP antagonists , including rimegepant (Nurtec ODT), ubrogepant (Ubrelvy), or zavegepant (Zavzpret), some of which are available as oral tablets or nasal sprays